Document Detail


Does prostaglandin E1 infusion affect the left ventricular filling pattern of end-stage dilated cardiomyopathy? A combined hemodynamic-echo Doppler study.
MedLine Citation:
PMID:  9057067     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Prostaglandin E1 improves hemodynamics in patients with severe dilated cardiomyopathy and pulmonary hypertension through it's reducing action on pulmonary resistances. However, few data are available to indicate whether these beneficial effects on right heart hemodynamics translate into any improvement of the altered left ventricular filling pattern that characterizes this condition. We studied 12 patients with dilated cardiomyopathy during preoperative evaluation for cardiac transplantation before and after prostaglandin E1, 30-50 ng/kg/min i.v. Patients underwent catheterization of the right heart and left ventricle by Swan-Ganz catheter, giving simultaneous assessment of pressure by micromanometer and of volume derived from two-dimensional echo-guided Doppler mitral flow velocity, where volume equals mitral velocity integral x valvular area. Prostaglandin E1 induced a significant reduction in mean pulmonary (from 38 to 30 mm Hg; p = 0.0001) and aortic (from 79 to 75 mm Hg, p = 0.05) pressures but no change in heart rate or tau. Peak A wave increased from 28 to 33 cm/s (p = 0.02), along with a reduction in end-diastolic pressure from 29 to 26 mm Hg (p < 0.04), whereas peak E wave did not change. E/A ratio decreased slightly (from 2.5 to 2.1; p < 0.0007) but did not reverse. Systolic volumes decreased (from 231 to 212 ml; p < 0.05), and cardiac index increased from 2.1 to 2.6 L/min/m2 (p = 0.0002) because of a reduction in pulmonary and systemic vascular resistances. The diastolic pressure-volume relation shifted downward along the same curve. Prostaglandin E1 infusion in patients with severe dilated cardiomyopathy and pulmonary hypertension reduces pulmonary and systemic resistances without affecting heart rate, relaxation, or passive diastolic left ventricular properties. Systolic right and left ventricular unloading increases cardiac index, facilitating ventricular emptying. E/A ratio does not reverse, although it decreases slightly, with mechanisms, however, that appear independent of any direct effect of the drug on the ventricular diastolic properties.
Authors:
P Marino; E Barbieri; M A Prioli; P Zardini
Related Documents :
3415377 - Hemodynamic consequences of right ventricular isolation: the contribution of the right ...
18947017 - Restrictive cardiomyopathy in a child.
426957 - Analysis of left ventricular behaviour in diastole by means of finite element method.
6733867 - Effect of right ventricular pressure on the end-diastolic left ventricular pressure-vol...
972127 - Sex and age differences in pulmonary mechanics in normal nonsmoking subjects.
19663607 - Chlorthalidone - a renaissance in use?
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Journal of cardiovascular pharmacology     Volume:  29     ISSN:  0160-2446     ISO Abbreviation:  J. Cardiovasc. Pharmacol.     Publication Date:  1997 Feb 
Date Detail:
Created Date:  1997-07-07     Completed Date:  1997-07-07     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  7902492     Medline TA:  J Cardiovasc Pharmacol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  188-95     Citation Subset:  IM    
Affiliation:
Division of Cardiology, University of Verona, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Alprostadil / pharmacology*
Cardiomyopathy, Dilated / physiopathology*
Echocardiography, Doppler
Female
Hemodynamics / drug effects
Humans
Male
Middle Aged
Mitral Valve Insufficiency / physiopathology
Reproducibility of Results
Ventricular Function, Left / drug effects*
Chemical
Reg. No./Substance:
745-65-3/Alprostadil

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Pharmacological studies on a new antihypertensive agent, S-2150, a benzothiazepine derivative: 3. Hy...
Next Document:  Influence of anesthetics on the incidence of reperfusion-induced arrhythmias and sudden death in rat...